Hemophilia Clinical and Cost Optimization for Managed Care and Specialty Pharmacy Web Activity


DISTINGUISHED FACULTY
Joan Couden, BSN, RN
National Director, Bleeding Disorder Program
Option Care

Click here for biography
Vanita K. Pindolia, PharmD, BCPS
Vice President, Ambulatory Clinical Pharmacy Programs_PCM
Henry Ford Health System/Health Alliance Plan of Michigan

Click here for biography
Steven W. Pipe, MD
Director, Division of Pediatric
Hematology and Oncology
Pediatric Medical Director, Hemophilia and Coagulation Disorders Program
University of Michigan

Click here for biography
Jonathan Roberts, MD
Associate Medical Director
Bleeding and Clotting Disorders Institute (BCDI)
Assistant Professor of Pediatrics
University of Illinois College of Medicine at Peoria

Click here for biography
Celynda G. Tadlock, PharmD, MBA
Vice President, Pharmacy Business Development
Aetna

Click here for biography
Michael Zeglinski, RPh
Senior Vice President, Specialty Pharmacy
OptumRx®/BriovaRx®

Click here for biography

TARGET AUDIENCE

Statement of Need/Program Overview
Due to the advent of new and more costly treatment modalities, the management of pediatric and adult hemophilia patients has become more complex for physicians, nurses, case managers, payers, specialty pharmacies, home health providers, and family/caregivers. In the absence of a coordinated educational effort, the full benefits of care coordination and the comprehensive care model have not yet been achieved.

This educational initiative will provide managed care and specialty pharmacy professionals with the latest information, presented by multi-disciplinary expert faculty, on the management of pediatric and adult hemophilia patients in health plan, specialty pharmacy, and other managed care settings. Represented on the faculty panel are Hemophilia Clinical Experts, Managed Care Experts, and Specialty Pharmacy Experts.

EDUCATIONAL OBJECTIVES
After completing this activity, the participant should be better able to:

ACCREDITATION

Physician Continuing Medical Education

Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Medical Education Resources (MER), National Hemophilia Foundation, and Impact Education, LLC. MER is accredited by the ACCME to provide continuing medical education for physicians

Credit Designation
Medical Education Resources designates these enduring materials for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacist Continuing Education

Accreditation Statement 
Medical Education Resources (MER) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. MER designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.

Credit Designation (Tracks 1 & 2)
Medical Education Resources designates these continuing education activities for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.

Nursing Continuing Education

Nursing Accreditation Statement
Medical Education Resources is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. Medical Education Resources is accredited as a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299.

Credit Designation (Tracks 1 & 2)
These educational activities for 1.5 contact hours are provided by Medical Education Resources.

DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLOSURE OF CONFLICTS OF INTEREST
Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing its learners with high-quality activities that promote improvements or quality in health care and not the business interest of a commercial interest.

The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:

Name of Faculty Reported Financial Relationship
Joan Couden, BSN, RN Speakers’ Bureau: Option Care
Salary: Option Care
Vanita Pindolia, PharmD, BCPS No financial relationships to disclose.
Steven Pipe, MD Consulting Fees: Baxalta, part of Shire, CSL Behring, Novo Nordisk, Inc., Roche, UniQure
Contracted Research: Baxalta, part of Shire, Siemens
Jonathan Roberts, MD Consulting Fees: Baxalta, part of Shire, CSL Behring
Contracted Research: Baxalta, part of Shire
Celynda G. Tadlock, PharmD, MBA No financial relationships to disclose.
Michael Zeglinski, RPh No financial relationships to disclose.

The content managers reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:

Name of Content Manager Reported Financial Relationship
Steven Casebeer, MBA No financial relationships to disclose.
Michelle Rice No financial relationships to disclose.
Marla Feinstein No financial relationships to disclose.
Mike Pangrace No financial relationships to disclose.
MER Content Managers No financial relationships to disclose.

DISCLAIMER
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, Impact Education, LLC, and/or Novo Nordisk, Inc., Baxalta, part of Shire, Biogen, and Grifols. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Medical Education Resources, Impact Education, LLC, and/or Novo Nordisk, Inc., Baxalta, part of Shire, Biogen, and Grifols. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

METHOD OF PARTICIPATION AND REQUEST FOR CREDIT
There are no fees for participating and receiving CME/CE credit for this activity. During the period January 16, 2017 through October 30, 2018, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; 3) successfully complete the post-test with a score of 70% or better; 4) and complete the evaluation form. Upon completion of the full CME/CE activity, your certificate will be made available immediately to download and print.

For Pharmacists: Upon successfully completing the post-test with a score of 70% or better and the activity evaluation form, you may immediately submit your CPE credit to the NABP CPE Monitor Service. This may require you to add or update the e-profile ID/date of birth information saved in your account.

MEDIA
Internet

FEE INFORMATION
There is no fee for this educational activity.